Aptose Biosciences News

Aptose Biosciences | DEF 14A: Definitive information statements

May 15 11:50 ET

Aptose Biosciences | 10-Q: Quarterly report

May 14 17:11 ET

Aptose Biosciences | 8-K: Aptose Reports Results for the First Quarter 2024

May 14 16:21 ET

Aptose Biosciences | 4: Statement of changes in beneficial ownership of securities- LEDRU PHILIPPE

May 10 11:39 ET

Aptose Biosciences | 8-K: Current report

May 6 16:50 ET

Aptose Biosciences | 8-K: Current report

May 1 16:35 ET

Aptose Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 30 17:27 ET

Aptose Biosciences | 10-K/A: Annual report (Amendment)

Apr 29 17:22 ET

Aptose Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hanmi Pharmaceutical Co., Ltd.(19.02%)

Apr 26 12:58 ET

Aptose Biosciences | 8-K: Current report

Apr 26 07:33 ET

Aptose Biosciences | 8-K: Current report

Apr 5 17:10 ET

Aptose Biosciences | 10-K: Annual report

Mar 26 17:05 ET

Aptose Biosciences | 8-K: Aptose Reports Results for the Fourth Quarter and Full Year 2023

Mar 26 16:08 ET

Aptose Biosciences | 8-K: Current report

Mar 18 16:46 ET

Aptose Biosciences | 8-K: Current report

Mar 1 17:07 ET

Aptose Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nantahala Capital Management, LLC(1.5%),Wilmot B. Harkey(1.5%), etc.

Feb 14 16:58 ET

Aptose Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Payne Fletcher

Feb 7 18:12 ET

Aptose Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Bejar Rafael

Feb 7 17:47 ET

Aptose Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer LEDRU PHILIPPE

Feb 7 17:27 ET

Aptose Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Rice William G.

Feb 7 17:18 ET